Skip to content

Sensory Training for Visual Motion Sickness

High-precision Immersive Robotic Environment for Sensorimotor Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04420949
Enrollment
10
Registered
2020-06-09
Start date
2021-03-19
Completion date
2021-06-30
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dizziness, Motion Sickness, Vertigo

Keywords

verticality, postural balance, visual dependence

Brief summary

This is a preliminary study to determine the reliability and validity of new tests of orientation and balance, as well as to test the effects of a new treatment for visually induced dizziness. Tests involve determining vertical alignment. The treatment is task-based and involves focusing attention on internal body sensations to help improve the sense of upright. Testing is done twice before and twice after treatment, which is provided twice-weekly during a three-week period between testing. The total time participants are involved in the study is approximately six weeks.

Detailed description

Falls are a major concern for people living in countries all over the world. Tens of millions of people who fall are seriously injured and hundreds of thousands of people who fall die every year. People who are dizzy are far more likely to fall. The investigators are particularly interested in working with people who have dizziness that is caused by watching motion or looking at complex patterns (e.g. checkerboard patterns, walking through grocery store aisles, riding in vehicles, or watching movies). This type of dizziness or vertigo is typically described as motion sickness or, more specifically, visually-induced dizziness. This problem affects adults who are healthy and adults who have a variety of health conditions. No diagnostic tests for this condition exist at this time and the treatments currently being used may result in worsening dizziness for some patients. New tests were created for orientation and balance, as well as a new treatment for visually-induced dizziness. This is a preliminary study of the reliability and validity of the tests we developed, as well as whether the new treatment created results in reduced dizziness, improved balance, and changes in daily functioning. It is not known whether the new tests of orientation and balance are better, worse, or the same as existing tests in the ability to detect problems, nor is it known if the new treatment technique is any better, worse, or the same as existing treatments for dizziness and imbalance. It is hypothesized that the new tests will be accurate and able to detect problems in impaired adults. Additionally, that the treatment will result in less dizziness, better balance, and reduced risk of falling. The plan is to enroll a total of 30 people in this study, 15 who are healthy and 15 who have visually-induced dizziness due to a vestibular (inner ear) problem. Each participant will complete several questionnaires and tests of balance performance before and after undergoing the treatment. Participants attend 8 visits over 6 weeks. Each study visit lasts approximately 60 minutes. During visits 1 and 2, which is a double baseline phase, the reliability and validity of the new testing procedures will be assessed. All participants will then enter the treatment phase (visits 2 through 7) and will attend twice-weekly appointments for three consecutive weeks. Following the treatment phase, participants will be re-assessed twice, immediately after (visit 7) and one week after (visit 8) completing treatment. During this phase, the short-term effectiveness of the treatment will be assessed. Participants will complete questionnaires that measure the intensity of visually-induced dizziness, perceived handicap due to dizziness, and the impact of dizziness on daily functioning. Performance measures include the ability to determine what is upright based on the internal sense of gravity (verticality), standing upright, and walking-related balance tasks. The verticality tests are performed while the participant is secured in a harness and are either standing upright or tilted to the left or to the right. The testing task is to determine upright based on using internal body sensations. The standing balance test is performed on a platform that measures balance. The verticality tests and the standing balance test are experimental. The treatment is task-based and is performed while the participant is supported in a harness and wearing virtual reality goggles. During the treatment, participants are either standing upright or tilted to the left or to the right. The treatment involves focusing attention on internal body sensations to help determine whether an image that is presented in an otherwise black virtual environment is aligned with gravity. Other visual and sound cues will be eliminated to prevent the use of these cues from influencing decisions about what is upright. As the participant becomes more successful at determining what is upright, the difficulty of the treatment task is gradually increased. Participants symptoms will be monitored throughout the testing and treatment. Participants are given regular rest breaks and may request to rest at any time. Participation is voluntary and may be discontinued at any time. The investigators anticipate only mild and infrequent side effects related to testing and treatment. The results of this study may influence how orientation and balance are assessed and how visually-induced dizziness is treated.

Interventions

During training, sensory re-weighting is driven by priming upregulation of somatosensory cues. Two rounds of training, each lasting 15 minutes and block-randomized in sets of 10 trials, are conducted per training visit. In each training trial, participants must determine the direction of gravity and then indicate if the rod being displayed is aligned with gravity or if it needs to rotate clockwise or counterclockwise for that to be so. Participants will be instructed to pay attention to what they feel from their feet, legs, and gut during training and to use that pressure, stretch, movement, and muscle tension feedback to help them sense gravity. Immediate auditory and non-orienting, visual feedback is provided after each trial. A staircase method is used to adapt the level of difficulty based on response accuracy. After two consecutive correct responses, the difficulty increases. After each incorrect response, the difficulty decreases. This process is repeated in each round.

Sponsors

National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

It is not possible to mask this behavioral intervention. The study team small; thus, masking of the study team is also not possible.

Intervention model description

The study will be conducted in three phases. The first phase is for baseline testing. The second phase is when treatment occurs. The third phase is for follow up testing. Participants will be tested twice during the baseline and follow up phases. Six treatment sessions will occur during the treatment phase.

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy Participants: Inclusion Criteria: Participants must * have normal self-reported cognitive function * speak English fluently * weigh less than 225 pounds and be less than 6'4 * be able to support their body weight in an upright posture for 15 minutes at a time * be able to follow the guidelines regarding permitted and prohibited additional treatments outlined in this protocol

Exclusion criteria

Participants must not * be pregnant or planning to become pregnant while in on study status * have best-corrected visual acuity \> 20/70 * have a self-reported, uncompensated, binocular vision abnormality, such as strabismus, amblyopia, or diplopia * have peripheral neuropathy * have a self-reported history of frequent syncope (\>1/month) Participants with Visually-induced Dizziness: Inclusion Criteria: Participants must * have self-reported symptoms of visually-induced dizziness * have normal self-reported cognitive function * speak English fluently * weigh less than 225 pounds and be less than 6'4 * be able to support their body weight in an upright posture for 15 minutes at a time * be able to follow the guidelines regarding permitted and prohibited additional treatments outlined in this protocol

Design outcomes

Primary

MeasureTime frameDescription
Rod and Disk Test (RDT) Mean PerformanceVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, the mean performance in this population is 0.39 (sd 0.8). Higher scores indicate subjective visual vertical alignment that is farther away from earth vertical.
Rod and Frame Test (RFT) Mean PerformanceVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)An image of a rod will be projected inside a tilted frame within the central portion of the visual field. The surrounding virtual environment will be void. The frame will be tilted by +/- 20° in the frontal plane. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, mean performance in this population is 6.51 (sd 7.8). Higher values indicate greater deviations of perceived vertical from earth vertical.
Subjective Visual Vertical (SVV) Mean PerformanceVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, the mean performance in this population is 0.39 (sd 0.8). Higher scores indicate subjective visual vertical alignment that is farther away from earth vertical.
Multisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)This test is designed to assess balance during quiet standing in different sensory conditions. Participants perform one trial (lasting 30 seconds) of each condition. All trials are performed while standing on a force plate with the feet in a self-selected, comfortable position. The visual environment is controlled using an Oculus Rift. The surface conditions are either non-compliant or compliant. The frequency-dependent height of the Intersection Point (IP) of the ground reaction force is the main metric. The overall height of the IP curve obtained while the participant stands on a firm surface with their eyes open is the primary outcome. The height of IP ranges from 0 to 4.0, and higher values represent greater stability.

Secondary

MeasureTime frameDescription
Vision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)The VRDQ is used to quantify vision-related dizziness. This outcome measure consists of 25 questions comprising two subscales \[frequency and severity of symptoms\]. The range of scores for each sub-scale is 0 to 100 points. The total score is the average of both sub-scales. Higher scores represent greater frequency and severity of symptoms. Test-retest reliability for the VRDQ is well above the good performance level and convergent validity for the VRDQ was demonstrated with the Dizziness Handicap Inventory (DHI). Spearman correlation coefficients are 0.75 between the DHI and VRDQ frequency scale and 0.76 between the DHI and VRDQ severity scale.
Dizziness Handicap Inventory (DHI) Total ScoreVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)The DHI is used to assess the severity of self-perceived disability secondary to dizziness. The tool is comprised of 25 questions which are score as yes = 4 points, sometimes = 2 points, and no = 0 points. The total score has a range of 0 to 100 points. The reliability and validity of the DHI have been established.

Other

MeasureTime frameDescription
Vestibular Activities and Participation Measure (VAPM) Average ScoreVisit 1 (Week 1) and Visit 8 (Week 5)The VAPM is a 34-item questionnaire that is used to assess the impact of vestibular dysfunction on daily activities and participation in various life roles. The psychometrics for this tool have been established for adults with vestibular disorders. The average score ranges from 0 to 4. Higher scores indicate greater impact of vestibular symptoms on daily activities and participation in various life roles.
Walking SpeedVisit 1 (Week 1) and Visit 8 (Week 5)Gait speed has been shown to be a reliable and valid measure of functional balance in adults. Gait speed will be recorded during a 10-meter walk test. Participants will walk for 2-meters before entering and after exiting the 6-meter long recording section. A stopwatch will be used for timing.
Functional Gait Assessment (FGA) Total ScoreVisit 1 (Week 1) and Visit 8 (Week 5)The FGA is a 10-item, observational, test of walking. Score for each item range from 0 to 3 and, thus, the total score ranges from 0 to 30. Use of an assistive device is permitted. Higher scores indicate greater stability during walking. The psychometrics of the FGA have been established for adults with balance disorders.
Vestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the TrialVisit 1 (Week 1) and Visit 8 (Week 5)The VRBQ was developed to assess outcomes from vestibular rehabilitation. The 22 questions are based on a literature review, participant interviews, and items from other measures. These questions are divided into three sub-scales: dizziness and anxiety (6), motion provoked dizziness (5), and quality of life (11). The total score ranges from 0-100 percent and scores \> 0 percent indicate the presence of symptoms, functional loss, or decreased quality of life. See http://www.isvr.soton.ac.uk/audiology/vrbq.htm for more information regarding the scoring methodology. It has been validated against other measures. The VRBQ is designed to measure the difference between the participant's current state of symptoms and quality of life compared to a state that is normal for the individual.
Activities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)The ABCS is a measure of balance-related confidence. The scale is made up of 16 questions for which respondents rate their level of perceived confidence in not becoming unsteady or falling. The average score ranges from 0 to 100 percent. Higher scores indicate greater balance-related confidence. The reliability and validity of the ABCS has been established in adults with and without a history of falling.

Countries

United States

Participant flow

Participants by arm

ArmCount
Healthy
Healthy adults with visually-induced dizziness with undergo the testing and treatment. Sensory re-weighting: During training, sensory re-weighting is driven by priming upregulation of somatosensory cues. Two rounds of training, each lasting 15 minutes and block-randomized in sets of 10 trials, are conducted per training visit. In each training trial, participants must determine the direction of gravity and then indicate if the rod being displayed is aligned with gravity or if it needs to rotate clockwise or counterclockwise for that to be so. Participants will be instructed to pay attention to what they feel from their feet, legs, and gut during training and to use that pressure, stretch, movement, and muscle tension feedback to help them sense gravity. Immediate auditory and non-orienting, visual feedback is provided after each trial. A staircase method is used to adapt the level of difficulty based on response accuracy. After two consecutive correct responses, the difficulty increases. After each incorrect response, the difficulty decreases. This process is repeated in each round.
5
Vestibular-impaired
Adults with unilateral or bilateral, peripheral vestibular loss who also have visually-induced dizziness with undergo the testing and treatment. Sensory re-weighting: During training, sensory re-weighting is driven by priming upregulation of somatosensory cues. Two rounds of training, each lasting 15 minutes and block-randomized in sets of 10 trials, are conducted per training visit. In each training trial, participants must determine the direction of gravity and then indicate if the rod being displayed is aligned with gravity or if it needs to rotate clockwise or counterclockwise for that to be so. Participants will be instructed to pay attention to what they feel from their feet, legs, and gut during training and to use that pressure, stretch, movement, and muscle tension feedback to help them sense gravity. Immediate auditory and non-orienting, visual feedback is provided after each trial. A staircase method is used to adapt the level of difficulty based on response accuracy. After two consecutive correct responses, the difficulty increases. After each incorrect response, the difficulty decreases. This process is repeated in each round.
5
Total10

Baseline characteristics

CharacteristicHealthyTotalVestibular-impaired
Age, Continuous41.02 years
STANDARD_DEVIATION 16.14
42.07 years
STANDARD_DEVIATION 15.56
43.12 years
STANDARD_DEVIATION 16.78
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
5 Participants10 Participants5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
4 Participants9 Participants5 Participants
Region of Enrollment
United States
5 participants10 participants5 participants
Sex: Female, Male
Female
5 Participants10 Participants5 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Visual Vertigo Analog Scale (VVAS)0 units on a scale
STANDARD_DEVIATION 0
81.7 units on a scale
STANDARD_DEVIATION 132
163.4 units on a scale
STANDARD_DEVIATION 150.8

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 5
other
Total, other adverse events
0 / 50 / 5
serious
Total, serious adverse events
0 / 50 / 5

Outcome results

Primary

Multisensory Balance Evaluation (MBE) as Measured by the Intersection Point Height

This test is designed to assess balance during quiet standing in different sensory conditions. Participants perform one trial (lasting 30 seconds) of each condition. All trials are performed while standing on a force plate with the feet in a self-selected, comfortable position. The visual environment is controlled using an Oculus Rift. The surface conditions are either non-compliant or compliant. The frequency-dependent height of the Intersection Point (IP) of the ground reaction force is the main metric. The overall height of the IP curve obtained while the participant stands on a firm surface with their eyes open is the primary outcome. The height of IP ranges from 0 to 4.0, and higher values represent greater stability.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 10.5 metersStandard Deviation 0.23
HealthyMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 20.42 metersStandard Deviation 0.18
HealthyMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 70.37 metersStandard Deviation 0.17
HealthyMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 80.46 metersStandard Deviation 0.15
Vestibular-impairedMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 80.37 metersStandard Deviation 0.11
Vestibular-impairedMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 10.53 metersStandard Deviation 0.17
Vestibular-impairedMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 70.39 metersStandard Deviation 0.08
Vestibular-impairedMultisensory Balance Evaluation (MBE) as Measured by the Intersection Point HeightVisit 20.52 metersStandard Deviation 0.15
Primary

Rod and Disk Test (RDT) Mean Performance

An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, the mean performance in this population is 0.39 (sd 0.8). Higher scores indicate subjective visual vertical alignment that is farther away from earth vertical.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyRod and Disk Test (RDT) Mean PerformanceVisit 117 degreesStandard Deviation 7.5
HealthyRod and Disk Test (RDT) Mean PerformanceVisit 27.8 degreesStandard Deviation 8.8
HealthyRod and Disk Test (RDT) Mean PerformanceVisit 712.4 degreesStandard Deviation 6.7
HealthyRod and Disk Test (RDT) Mean PerformanceVisit 812.6 degreesStandard Deviation 5.3
Vestibular-impairedRod and Disk Test (RDT) Mean PerformanceVisit 810.3 degreesStandard Deviation 7
Vestibular-impairedRod and Disk Test (RDT) Mean PerformanceVisit 113.3 degreesStandard Deviation 4
Vestibular-impairedRod and Disk Test (RDT) Mean PerformanceVisit 710.3 degreesStandard Deviation 4.4
Vestibular-impairedRod and Disk Test (RDT) Mean PerformanceVisit 212.1 degreesStandard Deviation 6.7
Primary

Rod and Frame Test (RFT) Mean Performance

An image of a rod will be projected inside a tilted frame within the central portion of the visual field. The surrounding virtual environment will be void. The frame will be tilted by +/- 20° in the frontal plane. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, mean performance in this population is 6.51 (sd 7.8). Higher values indicate greater deviations of perceived vertical from earth vertical.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyRod and Frame Test (RFT) Mean PerformanceVisit 13.9 degreesStandard Deviation 4.9
HealthyRod and Frame Test (RFT) Mean PerformanceVisit 25.7 degreesStandard Deviation 4.3
HealthyRod and Frame Test (RFT) Mean PerformanceVisit 75.6 degreesStandard Deviation 1.7
HealthyRod and Frame Test (RFT) Mean PerformanceVisit 87.6 degreesStandard Deviation 1.9
Vestibular-impairedRod and Frame Test (RFT) Mean PerformanceVisit 85.9 degreesStandard Deviation 3.45
Vestibular-impairedRod and Frame Test (RFT) Mean PerformanceVisit 17.9 degreesStandard Deviation 2.9
Vestibular-impairedRod and Frame Test (RFT) Mean PerformanceVisit 78.2 degreesStandard Deviation 6.1
Vestibular-impairedRod and Frame Test (RFT) Mean PerformanceVisit 27.2 degreesStandard Deviation 3.3
Primary

Subjective Visual Vertical (SVV) Mean Performance

An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, the mean performance in this population is 0.39 (sd 0.8). Higher scores indicate subjective visual vertical alignment that is farther away from earth vertical.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthySubjective Visual Vertical (SVV) Mean PerformanceVisit 1-1.34 degreesStandard Deviation 1.65
HealthySubjective Visual Vertical (SVV) Mean PerformanceVisit 2-1.14 degreesStandard Deviation 1.36
HealthySubjective Visual Vertical (SVV) Mean PerformanceVisit 7-.21 degreesStandard Deviation 0.5
HealthySubjective Visual Vertical (SVV) Mean PerformanceVisit 81.0 degreesStandard Deviation 1.85
Vestibular-impairedSubjective Visual Vertical (SVV) Mean PerformanceVisit 8-2.22 degreesStandard Deviation 2.08
Vestibular-impairedSubjective Visual Vertical (SVV) Mean PerformanceVisit 1-1.3 degreesStandard Deviation 3.76
Vestibular-impairedSubjective Visual Vertical (SVV) Mean PerformanceVisit 7-1.96 degreesStandard Deviation 1.17
Vestibular-impairedSubjective Visual Vertical (SVV) Mean PerformanceVisit 2-1.4 degreesStandard Deviation 1.86
Secondary

Dizziness Handicap Inventory (DHI) Total Score

The DHI is used to assess the severity of self-perceived disability secondary to dizziness. The tool is comprised of 25 questions which are score as yes = 4 points, sometimes = 2 points, and no = 0 points. The total score has a range of 0 to 100 points. The reliability and validity of the DHI have been established.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyDizziness Handicap Inventory (DHI) Total ScoreVisit 10.4 units on a scaleStandard Deviation 0.9
HealthyDizziness Handicap Inventory (DHI) Total ScoreVisit 20.4 units on a scaleStandard Deviation 0.9
HealthyDizziness Handicap Inventory (DHI) Total ScoreVisit 71 units on a scaleStandard Deviation 2
HealthyDizziness Handicap Inventory (DHI) Total ScoreVisit 80.8 units on a scaleStandard Deviation 1.1
Vestibular-impairedDizziness Handicap Inventory (DHI) Total ScoreVisit 818.4 units on a scaleStandard Deviation 24.5
Vestibular-impairedDizziness Handicap Inventory (DHI) Total ScoreVisit 119.2 units on a scaleStandard Deviation 22
Vestibular-impairedDizziness Handicap Inventory (DHI) Total ScoreVisit 723 units on a scaleStandard Deviation 27
Vestibular-impairedDizziness Handicap Inventory (DHI) Total ScoreVisit 224.4 units on a scaleStandard Deviation 22.4
Secondary

Vision-related Dizziness Questionnaire (VRDQ) Total Score

The VRDQ is used to quantify vision-related dizziness. This outcome measure consists of 25 questions comprising two subscales \[frequency and severity of symptoms\]. The range of scores for each sub-scale is 0 to 100 points. The total score is the average of both sub-scales. Higher scores represent greater frequency and severity of symptoms. Test-retest reliability for the VRDQ is well above the good performance level and convergent validity for the VRDQ was demonstrated with the Dizziness Handicap Inventory (DHI). Spearman correlation coefficients are 0.75 between the DHI and VRDQ frequency scale and 0.76 between the DHI and VRDQ severity scale.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 10 units on a scaleStandard Deviation 0
HealthyVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 20 units on a scaleStandard Deviation 0
HealthyVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 70 units on a scaleStandard Deviation 0
HealthyVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 80 units on a scaleStandard Deviation 0
Vestibular-impairedVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 876 units on a scaleStandard Deviation 76
Vestibular-impairedVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 190.8 units on a scaleStandard Deviation 90
Vestibular-impairedVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 774 units on a scaleStandard Deviation 103
Vestibular-impairedVision-related Dizziness Questionnaire (VRDQ) Total ScoreVisit 286 units on a scaleStandard Deviation 80
Other Pre-specified

Activities-specific Balance Confidence Scale (ABCS) Average Score

The ABCS is a measure of balance-related confidence. The scale is made up of 16 questions for which respondents rate their level of perceived confidence in not becoming unsteady or falling. The average score ranges from 0 to 100 percent. Higher scores indicate greater balance-related confidence. The reliability and validity of the ABCS has been established in adults with and without a history of falling.

Time frame: Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 199 percentStandard Deviation 0.8
HealthyActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 299 percentStandard Deviation 1
HealthyActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 799 percentStandard Deviation 1.3
HealthyActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 899 percentStandard Deviation 0.7
Vestibular-impairedActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 895.6 percentStandard Deviation 6.7
Vestibular-impairedActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 191.8 percentStandard Deviation 10
Vestibular-impairedActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 793.5 percentStandard Deviation 7.6
Vestibular-impairedActivities-specific Balance Confidence Scale (ABCS) Average ScoreVisit 288 percentStandard Deviation 15
Other Pre-specified

Functional Gait Assessment (FGA) Total Score

The FGA is a 10-item, observational, test of walking. Score for each item range from 0 to 3 and, thus, the total score ranges from 0 to 30. Use of an assistive device is permitted. Higher scores indicate greater stability during walking. The psychometrics of the FGA have been established for adults with balance disorders.

Time frame: Visit 1 (Week 1) and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyFunctional Gait Assessment (FGA) Total ScoreVisit 128.8 units on a scaleStandard Deviation 1.6
HealthyFunctional Gait Assessment (FGA) Total ScoreVisit 829.6 units on a scaleStandard Deviation 0.89
Vestibular-impairedFunctional Gait Assessment (FGA) Total ScoreVisit 129 units on a scaleStandard Deviation 1.7
Vestibular-impairedFunctional Gait Assessment (FGA) Total ScoreVisit 829.3 units on a scaleStandard Deviation 1.5
Other Pre-specified

Vestibular Activities and Participation Measure (VAPM) Average Score

The VAPM is a 34-item questionnaire that is used to assess the impact of vestibular dysfunction on daily activities and participation in various life roles. The psychometrics for this tool have been established for adults with vestibular disorders. The average score ranges from 0 to 4. Higher scores indicate greater impact of vestibular symptoms on daily activities and participation in various life roles.

Time frame: Visit 1 (Week 1) and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyVestibular Activities and Participation Measure (VAPM) Average ScoreVisit 10 units on a scaleStandard Deviation 0
HealthyVestibular Activities and Participation Measure (VAPM) Average ScoreVisit 80 units on a scaleStandard Deviation 0
Vestibular-impairedVestibular Activities and Participation Measure (VAPM) Average ScoreVisit 10.84 units on a scaleStandard Deviation 0.79
Vestibular-impairedVestibular Activities and Participation Measure (VAPM) Average ScoreVisit 80.33 units on a scaleStandard Deviation 0.48
Other Pre-specified

Vestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the Trial

The VRBQ was developed to assess outcomes from vestibular rehabilitation. The 22 questions are based on a literature review, participant interviews, and items from other measures. These questions are divided into three sub-scales: dizziness and anxiety (6), motion provoked dizziness (5), and quality of life (11). The total score ranges from 0-100 percent and scores \> 0 percent indicate the presence of symptoms, functional loss, or decreased quality of life. See http://www.isvr.soton.ac.uk/audiology/vrbq.htm for more information regarding the scoring methodology. It has been validated against other measures. The VRBQ is designed to measure the difference between the participant's current state of symptoms and quality of life compared to a state that is normal for the individual.

Time frame: Visit 1 (Week 1) and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyVestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the TrialVisit 15.4 percentStandard Deviation 3.8
HealthyVestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the TrialVisit 82 percentStandard Deviation 2.5
Vestibular-impairedVestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the TrialVisit 127.8 percentStandard Deviation 27.7
Vestibular-impairedVestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the TrialVisit 820.2 percentStandard Deviation 28.4
Other Pre-specified

Walking Speed

Gait speed has been shown to be a reliable and valid measure of functional balance in adults. Gait speed will be recorded during a 10-meter walk test. Participants will walk for 2-meters before entering and after exiting the 6-meter long recording section. A stopwatch will be used for timing.

Time frame: Visit 1 (Week 1) and Visit 8 (Week 5)

ArmMeasureGroupValue (MEAN)Dispersion
HealthyWalking SpeedVisit 12.14 meters per secondStandard Deviation 0.2
HealthyWalking SpeedVisit 82.17 meters per secondStandard Deviation 0.27
Vestibular-impairedWalking SpeedVisit 12.05 meters per secondStandard Deviation 0.46
Vestibular-impairedWalking SpeedVisit 82.17 meters per secondStandard Deviation 0.18

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026